G1 THERAPEUTICS INC's ticker is GTHX and the CUSIP is 3621LQ109. A total of 102 filers reported holding G1 THERAPEUTICS INC in Q3 2019. The put-call ratio across all filers is 6.79 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2020 | $2,062,000 | -30.2% | 178,485 | +46.6% | 0.04% | -36.7% |
Q2 2020 | $2,954,000 | +840.8% | 121,766 | +327.5% | 0.06% | +650.0% |
Q1 2020 | $314,000 | -95.3% | 28,486 | -88.7% | 0.01% | -93.8% |
Q4 2019 | $6,678,000 | +24.3% | 252,673 | +7.2% | 0.13% | +16.4% |
Q3 2019 | $5,371,000 | – | 235,761 | – | 0.11% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
MPM BioImpact LLC | 650,000 | $3,529,500 | 0.92% |
CHI Advisors LLC | 333,945 | $1,813,321 | 0.48% |
PVG ASSET MANAGEMENT CORP | 15,585 | $84,626 | 0.37% |
Rhenman & Partners Asset Management AB | 370,000 | $2,009,100 | 0.21% |
NEEDHAM INVESTMENT MANAGEMENT LLC | 184,000 | $999,120 | 0.18% |
Birchview Capital, LP | 40,000 | $217 | 0.15% |
XTX Topco Ltd | 102,282 | $555,391 | 0.12% |
Tekla Capital Management LLC | 423,869 | $2,301,609 | 0.09% |
Woodline Partners LP | 1,028,967 | $5,587,291 | 0.08% |
Curi Wealth Management, LLC | 81,009 | $439,879 | 0.06% |